Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques

Genes Chromosomes and Cancer

Volumn 47, Issue 12, 2008, Pages 1086-1097

  Salaverria, Itziar ^a   Espinet, Blanca ^b   Carrió, Ana ^a   Costa, Dolors ^a   Astier, Laura ^b   Slotta Huspenina, Julia ^c   Quintanilla Martinez, Leticia ^d   Fend, Falko ^e   Solé, Francesc ^b   Colomer, Dolors ^a   Serrano, Sergio ^b   Miró, Rosa ^f   Beà, Sílvia ^a,g   Campo, Elías ^a,g  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^f UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATM GENE; CELL LINE; CHROMOSOME 1; CHROMOSOME 10; CHROMOSOME 11; CHROMOSOME 14; CHROMOSOME 1P; CHROMOSOME 8; CHROMOSOME 8P; CHROMOSOME 9; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CHROMOSOME STRUCTURE; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE DELETION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MALE; MANTLE CELL LYMPHOMA; MOLECULAR GENETICS; PATHOGENESIS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME BREAKAGE; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; CYTOGENETIC ANALYSIS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; TRANSLOCATION, GENETIC;

EID: 57149110223     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20609     Document Type: Article

References (47)

1. Allen JE, Hough RE, Goepel JR, Bottomley S, Wilson GA, Alcock HE, Baird M, Lorigan PC, Vandenberghe EA, Hancock BW, Hammond DW. 2002. Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization. Br J Haematol 116:291-298.
2. Au WY, Gascoyne RD, Viswanatha DS, Connors JM, Klasa RJ, Horsman DE. 2002. Cytogenetic analysis in mantle cell lymphoma: A review of 214 cases. Leuk Lymphoma 43:783-791.
3. Balakrishnan A, Von Neuhoff N, Rudolph C, Kamphues K, Schraders M, Groenen P, van Krieken JH, Callet-Bauchu E, Schlegelberger B, Steinemann D. 2006. Quantitative microsatellite analysis to delineate the commonly deleted region 1p22.3 in mantle cell lymphomas. Genes Chromosomes Cancer 45:883-892.
4. Baro C, Salido M, Espinet B, Astier L, Domingo A, Granada I, Milla F, Carrio A, Costa D, Luno E, Hernandez JM, Campo E, Florensa L, Ferrer A, Salar A, Bellosillo B, Besses C, Serrano S, Sole F. 2008. New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY). Leuk Res 32:727-736.
5. Bea S, Ribas M, Hernandez JM, Bosch F, Pinyol M, Hernandez L, Garcia JL, Flores T, Gonzalez M, Lopez-Guillermo A, Piris MA, Cardesa A, Montserrat E, Miro R, Campo E. 1999. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood 93:4365-4374.
6. Bea S, Campo E. 2008. Secondary genomic alterations in non-Hodgkin Lymphomas: Tumor specific profiles with impact in clinical behavior. Haematologica 93:641-645.
7. Bentz M, Plesch A, Bullinger L, Stilgenbauer S, Ott G, Muller-Hermelink HK, Baudis M, Barth TF, Moller P, Lichter P, Dohner H. 2000. t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer 27:285-294.
8. Bosga-Bouwer AG, Hendriks D, Vellenga E, Zorgdrager H, van den Berg E. 2001. Cytogenetic analysis of cryopreserved bone marrow cells. Cancer Genet Cytogenet 124:165-168.
9. Camacho E, Hernandez L, Hernandez S, Tort F, Bellosillo B, Bea S, Bosch F, Montserrat E, Cardesa A, Fernandez PL, Campo E. 2002. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Blood 99:238-244.
10. Camps J, Salaverria I, Garcia MJ, Prat E, Bea S, Pole JC, Hernandez L, Del Rey J, Cigudosa JC, Bernues M, Caldas C, Colomer D, Miro R, Campo E. 2006. Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines. Leuk Res 30:923-934.
11. Cuneo A, Bigoni R, Rigolin GM, Roberti MG, Bardi A, Piva N, Milani R, Bullrich F, Veronese ML, Croce C, Birg F, Dohner H, Hagemeijer A, Castoldi G. 1999. Cytogenetic profile of lymphoma of follicle mantle lineage: Correlation with clinicobiologic features. Blood 93:1372-1380.
12. Espinet B, Sole F, Woessner S, Bosch F, Florensa L, Campo E, Costa D, Lloveras E, Vila RM, Besses C, Montserrat E, Sans-Sabrafen J. 1999. Translocation (11;14)(q13;q32) and preferential involvement of chromosomes 1, 2, 9, 13, and 17 in mantle cell lymphoma. Cancer Genet Cytogenet 111:92-98.
13. Ferreira B, Garcia JF, Suela J, Mollejo M, Camacho FI, Carro A, Montes S, Piris MA, Cigudosa JC. 2008. Comparative genome profiling across sub-types of low grade B cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia. Haematologica 93:670-679.
14. Gazzo S, de Colella JM, Callet-Bauchu E. 2006. Sequential fluorescence in situ hybridisation analysis for cryptic t(11;14)(q13;q32) in mantle cell lymphoma. Br J Haematol 134:452.
15. Gazzo S, Felman P, Berger F, Salles G, Magaud JP, Callet-Bauchu E. 2005. Atypical cytogenetic presentation of t(11;14) in mantle cell lymphoma. Haematologica 90:1708-1709.
16. Gruszka-Westwood AM, Atkinson S, Summersgill BM, Shipley J, Elnenaei MO, Jain P, Hamoudi RA, Kaeda JS, Wotherspoon AC, Matutes E, Catovsky D. 2002. Unusual case of leukemic mantle cell lymphoma with amplified CCND1/IGH fusion gene. Genes Chromosomes Cancer 33:206-212.
17. Gutierrez NC, Camps J, Hernandez JM, Garcia JL, Prat E, Gonzalez MB, Miro R, San Miguel JF. 2003. Multicolor fluorescence in situ hybridization studies in multiple myeloma and monoclonal gammopathy of undetermined significance. Hematol J 4:67-70.
18. Hirt C, Schuler F, Dolken L, Schmidt CA, Dolken G. 2004. Low prevalence of circulating t(11;14)(q13;q32)-positive cells in the peripheral blood of healthy individuals as detected by real-time quantitative PCR. Blood 104:904-905.
19. ISCN. 1995. An International System for Human Cytogenetic Nomenclature. Basel: S. Karger AG.
20. Jares P, Colomer D, Campo E. 2007. Genetic and molecular pathogenesis of mantle cell lymphoma: Perspectives for new targeted therapeutics. Nat Rev Cancer 7:750-762.
21. Jarosova M, Papajik T, Holzerova M, Dusek L, Pikalova Z, Lakoma I, Raida L, Faber E, Divoka M, Vlachova S, Prekopova I, Novosadova A, Pospisilova H, Indrak K. 2004. High incidence of unbalanced chromosomal changes in mantle cell lymphoma detected by comparative genomic hybridization. Leuk Lymphoma 45:1835-1846.
22. Karpova MB, Schoumans J, Blennow E, Ernberg I, Henter JI, Smirnov AF, Nordenskjold M, Fadeel B. 2006. Combined spectral karyotyping, comparative genomic hybridization, and in vitro apoptyping of a panel of Burkitt's lymphoma-derived B cell lines reveals an unexpected complexity of chromosomal aberrations and a recurrence of specific abnormalities in chemoresistant cell lines. Int J Oncol 28:605-617.
23. Kohlhammer H, Schwaenen C, Wessendorf S, Holzmann K, Kestler HA, Kienle D, Barth TF, Moller P, Ott G, Kalla J, Radlwimmer B, Pscherer A, Stilgenbauer S, Dohner H, Lichter P, Bentz M. 2004. Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. Blood 104:795-801.
24. Lai R, McDonnell TJ, O'Connor SL, Medeiros LJ, Oudat R, Keating M, Morgan MB, Curiel TJ, Ford RJ. 2002. Establishment and characterization of a new mantle cell lymphoma cell line, Mino. Leuk Res 26:849-855.
25. Lestou VS, Gascoyne RD, Sehn L, Ludkovski O, Chhanabhai M, Klasa RJ, Husson H, Freedman AS, Connors JM, Horsman DE. 2003. Multicolour fluorescence in situ hybridization analysis of t(14;18)-positive follicular lymphoma and correlation with gene expression data and clinical outcome. Br J Haematol 122:745-759.
26. Lovec H, Grzeschiczek A, Kowalski M-B, Moroy T. 1994. Cyclin D1/bcl-1 cooperates with myc genes in the generation of B- cell lymphomas in transgenic mice. EMBO J 13:3487-3495.
27. Maravelaki S, Burford A, Wotherspoon A, Joshi R, Matutes E, Catovsky D, Brito-Babapulle V. 2004. Molecular cytogenetic study of a mantle cell lymphoma with a complex translocation involving the CCND1 (11q13) region. Cancer Genet Cytogenet 154:67-71.
28. Martinez-Climent JA, Vizcarra E, Sanchez D, Blesa D, Marugan I, Benet I, Sole F, Rubio-Moscardo F, Terol MJ, Climent J, Sarsotti E, Tormo M, Andreu E, Salido M, Ruiz MA, Prosper F, Siebert R, Dyer MJ, Garcia-Conde J. 2001. Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma. Blood 98:3479-3482.
29. McConnell TS, Cordova LM, Baczek NA, Foucar K, Dewald GW. 1990. Chromosome analysis of cryopreserved cells. Cancer Genet Cytogenet 45:179-191.
30. M'kacher R, Farace F, Bennaceur-Griscelli A, Violot D, Clausse B, Dossou J, Valent A, Parmentier C, Ribrag V, Bosq J, Carde P, Turhan AG, Bernheim A. 2003. Blastoid mantle cell lymphoma: Evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse model. Cancer Genet Cytogenet 143:32-38.
31. Monni O, Oinonen R, Elonen E, Franssila K, Teerenhovi L, Joensuu H, Knuutila S. 1998. Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma. Genes Chromosomes Cancer 21:298-307.
32. Nagele RG, Freeman T, McMorrow L, Thomson Z, Kitson-Wind K, Lee H. 1999. Chromosomes exhibit preferential positioning in nuclei of quiescent human cells. J Cell Sci 112 (Pt 4):525-535.
33. Nanjangud G, Rao PH, Teruya-Feldstein J, Donnelly G, Qin J, Mehra S, Jhanwar SC, Zelenetz AD, Chaganti RS. 2007. Molecular cytogenetic analysis of follicular lymphoma (FL) provides detailed characterization of chromosomal instability associated with the t(14;18)(q32;q21) positive and negative subsets and histologic progression. Cytogenet Genome Res 118:337-344.
34. Rimokh R, Berger F, Delsol G, Digonnet I, Rouault JP, Tigaud JD, Gadoux M, Coiffier B, Bryon PA, Magaud P. 1994. Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood 83:1871-1875.
35. Rinaldi A, Kwee I, Taborelli M, Largo C, Uccella S, Martin V, Poretti G, Gaidano G, Calabrese G, Martinelli G, Baldini L, Pruneri G, Capella C, Zucca E, Cotter FE, Cigudosa JC, Catapano CV, Tibiletti MG, Bertoni F. 2006. Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma. Br J Haematol 132:303-316.
36. Rubio-Moscardo F, Climent J, Siebert R, Piris MA, Martin-Subero JI, Nielander I, Garcia-Conde J, Dyer MJ, Terol MJ, Pinkel D, Martinez-Climent JA. 2005. Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome. Blood 105:4445-4454.
37. Sachs RK, Chen AM, Brenner DJ. 1997. Review: Proximity effects in the production of chromosome aberrations by ionizing radiation. Int J Radiat Biol 71:1-19.
38. Salaverria I, Bea S, Lopez-Guillermo A, Lespinet V, Pinyol M, Burkhardt B, Lamant L, Zettl A, Horsman DE, Gascoyne RD, Ott G, Siebert R, Delsol G, Campo E. 2008. Genomic Profiling reveals different genetic aberration in systemic ALK-positive and ALK-negative Anaplastic Large Cell Lymphomas. Br J Haematol 140:516-526.
39. Salaverria I, Perez-Galan P, Colomer D, Campo E. 2006. Mantle cell lymphoma: From pathology and molecular pathogenesis to new therapeutic perspectives. Haematologica 91:11-16.
40. Salaverria I, Zettl A, Bea S, Moreno V, Valls J, Hartmann E, Ott G, Wright G, Lopez-Guillermo A, Chan WC, Weisenburger DD, Gascoyne RD, Grogan TM, Delabie J, Jaffe ES, Montserrat E, Muller-Hermelink HK, Staudt LM, Rosenwald A, Campo E. 2007. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature. J Clin Oncol 25:1216-1222.
41. Schraders M, Pfundt R, Straatman HM, Janssen IM, van Kessel AG, Schoenmakers EF, van Krieken JH, Groenen PJ. 2005. Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization. Blood 105:1686-1693.
42. Seto M, Yamamoto K, Iida S, Akao Y, Utsumi KR, Kubonishi I, Miyoshi I, Ohtsuki T, Yawata Y, Namba M. 1992. Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene 7:1401-1406.
43. Slotta-Huspenina J, Koch I, Richter M, Bink K, Kremer M, Specht K, Krugmann J, Quintanilla-Martinez L, Fend F. 2008. Cyclin D1 positive multiple myeloma: Predominance of the short, 3′UTR-deficient transcript is associated with high cyclin D1 mRNA levels in cases with t(11;14) translocation, but does not correlate with proliferation rate or genomic deletions. Leuk Res 32:79-88.
44. Tagawa H, Karnan S, Suzuki R, Matsuo K, Zhang X, Ota A, Morishima Y, Nakamura S, Seto M. 2005. Genome-wide array-based CGH for mantle cell lymphoma: Identification of homozygous deletions of the proapoptotic gene BIM. Oncogene 24:1348-1358.
45. Wiestner A, Tehrani M, Chiorazzi M, Wright G, Gibellini F, Nakayama K, Liu H, Rosenwald A, Muller-Hermelink HK, Ott G, Chan WC, Greiner TC, Weisenburger DD, Vose J, Armitage JO, Gascoyne RD, Connors JM, Campo E, Montserrat E, Bosch F, Smeland EB, Kvaloy S, Holte H, Delabie J, Fisher RI, Grogan TM, Miller TP, Wilson WH, Jaffe ES, Staudt LM. 2007. Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival. Blood 109: 4599-4606.
46. Wlodarska I, Pittaluga S, Hagemeijer A, Wolf-Peeters C, Van Den Berghe H. 1999. Secondary chromosome changes in mantle cell lymphoma. Haematologica 84:594-599.
47. Zhu Y, Monni O, Franssila K, Elonen E, Vilpo J, Joensuu H, Knuutila S. 2000. Deletions at 11q23 in different lymphoma subtypes. Haematologica 85:908-912.